ETH
ORIA

Exos TFP Holdings’s Orion Biotech Opportunities Corp. Class A Ordinary Share ORIA Stock Holding History

Exos TFP Holdings’s Portfolio ORIA Stock Details ORIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-43,029
Closed -$432K – 529
2022
Q4 		$432K Sell
43,029
-136
-0.3% -$1.35K 0.12% 164
2022
Q3 		$425K Buy
+43,165
New +$423K 0.19% 138

Other funds holding ORIA

AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return
FTCM
Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return
HSBC Holdings
HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return
CCA
Castle Creek Arbitrage Avon, Colorado $425M AUM 7.4% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Exos TFP Holdings's ORIA Position: Q1 2023 in Review

Exos TFP Holdings sold out of Orion Biotech Opportunities Corp. Class A Ordinary Share (ORIA) in Q1 2023, closing a stake of 43,029 shares — an estimated $432K sold.

Exos TFP Holdings first reported a position in ORIA in Q3 2022 and held it in 2 quarters. The position peaked at $432K in Q4 2022. 49 funds tracked by Wall St. Rank hold ORIA as of Q1 2023.

  • Exos TFP Holdings reported no remaining Orion Biotech Opportunities Corp. Class A Ordinary Share position as of Q1 2023 after selling out during the quarter.
  • Exos TFP Holdings sold 43,029 Orion Biotech Opportunities Corp. Class A Ordinary Share shares in Q1 2023, an estimated $432K.
  • Exos TFP Holdings first reported a position in Orion Biotech Opportunities Corp. Class A Ordinary Share in Q3 2022 and held it in 2 quarters.
  • Exos TFP Holdings's Orion Biotech Opportunities Corp. Class A Ordinary Share position peaked at $432K in Q4 2022.
  • 49 funds tracked by Wall St. Rank held Orion Biotech Opportunities Corp. Class A Ordinary Share as of Q1 2023.

Based on Exos TFP Holdings's 13F filing for Q1 2023, filed 10 May 2023.